Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Daiichi Sankyo to celebrate Evista’s tenth year

Daiichi Sankyo to celebrate Evista’s tenth year

20th May 2009

Daiichi Sankyo is delighted to mark the tenth birthday of Evista later this year, it has stated.

Prof Dr P Hadji from the University Hospital of Giessen and Marburg noted the drug ? intended to treat and prevent osteoporosis in postmenopausal women ? has a long and proven history of patient compliance.

He explained many other medications tend to be suboptimal and poor adherence has a negative effect on the patient.

The majority of women prescribed Evista stay on the therapy for the first two years, according to data presented at the eighth European Congress on Menopause.

“Years of research not only confirm that patients adhere to treatment regimens with the drug, but also demonstrate a safety profile that is as strong now as it was when [the drug] first came to market,” remarked Prof Dr Hadji.

The findings come before the treatment’s decade milestone in October.

Chief executive officer of Daiichi Sankyo Europe Reinhard Bauer commented: “The anniversary is intended to raise awareness of the disease and highlight the role that Evista has played.”

On International Women’s Day (March 8th), the company aimed to raise awareness among females about how a healthy lifestyle can help prevent or manage disease.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.